Poxel Appoints Khoso Baluch to Board

Biopharma startup Poxel has appointed Khoso Baluch to its board of directors. Baluch will serve as an independent director. He is senior vice president & president European region at UCB, the global biopharmaceutical company. Poxel is backed by Edmond de Rothschild Investment Partners, InnoBio and Omnes Capital.

21 March 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles